Skip to main content
I

INKON Life Technology Co., Ltd. — Investor Relations & Filings

Ticker · 300143 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 2,850 across all filing types
Latest filing 2026-04-17 Declaration of Voting R…
Country CN China
Listing Shenzhen Stock Exchange 300143

About INKON Life Technology Co., Ltd.

https://www.inkonlife.com

INKON Life Technology Co., Ltd. specializes in the development and manufacture of advanced medical equipment and digital healthcare solutions. The company focuses on two primary sectors: radiotherapy equipment and digital medical services. Its core product portfolio includes high-precision radiotherapy systems, such as the Gamma Knife, and medical infusion systems. INKON Life leverages Internet of Things (IoT) technology to provide integrated digital hospital solutions, aiming to improve clinical efficiency and patient outcomes. The company serves oncology centers and medical institutions by providing comprehensive cancer treatment solutions and smart healthcare management platforms. By combining medical engineering with digital innovation, INKON Life focuses on the modernization of radiotherapy and the digital transformation of healthcare delivery.

Recent filings

Filing Released Lang Actions
2025年年度股东会决议公告
Declaration of Voting Results & Voting Rights Announcements Classification · 1% confidence The document is an announcement of the resolutions and detailed voting results from the company’s 2025 Annual General Meeting (AGM). It lists the meeting convocation, attendance, and the vote counts/results for each agenda item, which matches the definition of “Declaration of Voting Results & Voting Rights Announcements” (code DVA).
2026-04-17 Chinese
关于召开2025年年度股东会的提示性公告
Proxy Solicitation & Information Statement Classification · 1% confidence The document is an official notice (“提示性公告”) of the company’s 2025 Annual General Meeting (AGM), detailing meeting date, location, agenda proposals, voting methods (including proxy voting), registration procedures, and proxy form attachments. It is not the AGM presentation materials themselves (AGM-R), nor is it the actual annual report or earnings release. Rather, it is proprietary meeting solicitation materials sent to shareholders to provide information and request votes, fitting the Proxy Solicitation & Information Statement category (PSI).
2026-04-10 Chinese
关于拟续聘会计师事务所的公告
Regulatory Filings
2026-03-27 Chinese
独立董事2025年度述职报告（姜峰）
Regulatory Filings
2026-03-27 Chinese
独立董事2025年度述职报告（陈晓满）
Regulatory Filings
2026-03-27 Chinese
关于举行2025年度报告网上业绩说明会的公告
Regulatory Filings
2026-03-27 Chinese

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.